Public and investor relations for the innovators in healthcare and technology

We’ve been delivering measurable PR and IR results for innovative companies in health and technology since our founding more than 30 years ago originally as Noonan/Russo Communications.  When it comes to raising awareness of your company and product as well as forging new relationships, no one connects you to the people you want to know like we do. Our team of PhD-level scientists, former journalists, TV producers, and Wall Street professionals is on a first-name basis with the who’s who in media, finance, medicine and technology.

SpinalCyte receives new regenerative medicine patents: 5 insights
| Becker's Spine Review

SpinalCyte was issued new patents in the U.S. and Japan. Five things to know: 1. SpinalCyte is a regenerative medicine company focused on spinal disc regrowth using human dermal fibroblasts. 2. The company’s CybroCell product is the first off-the-shelf allogenic human dermal fibroblast product. It’s used indegenerative disc disease treatments. 3. The patents describe methods to differentiate […]

read more
Regenerative Medicine Companies Successfully Advance Stem Cell Therapies
| Pharmaceutical Executive

Stem cell therapy development is a new area where several companies are emerging with promising results utilizing stem cell therapies. Some companies have failed, whereas others, such as Athersys, are succeeding. Gil Van Bokkelen, PhD, CEO of Athersys, will discuss his perspective on the recent advancements in stem cell therapies and their multiple application on […]

read more
Survivor doing what he can to help fight childhood cancer
| Click 2 Houston

Neuroblastoma accounts for 6 percent of all cancers in children, and is deadly in kids under 5. Many times, the cancer spreads to the lymph nodes before parents even notice a lump. Now, a 4-year-old boy who fought the disease is helping other kids fight back.

read more